Q16566 (KCC4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Calcium/calmodulin-dependent protein kinase type IV Short name=CaMK IV EC=2.7.11.17 Alternative name(s): CaM kinase-GR | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 473 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK4 signaling cascade and regulates, mainly by phosphorylation, the activity of several transcription activators, such as CREB1, MEF2D, JUN and RORA, which play pivotal roles in immune response, inflammation, and memory consolidation. In the thymus, regulates the CD4+/CD8+ double positive thymocytes selection threshold during T-cell ontogeny. In CD4 memory T-cells, is required to link T-cell antigen receptor (TCR) signaling to the production of IL2, IFNG and IL4 (through the regulation of CREB and MEF2). Regulates the differentiation and survival phases of osteoclasts and dendritic cells (DCs). Mediates DCs survival by linking TLR4 and the regulation of temporal expression of BCL2. Phosphorylates the transcription activator CREB1 on 'Ser-133' in hippocampal neuron nuclei and contribute to memory consolidation and long term potentiation (LTP) in the hippocampus. Can activate the MAP kinases MAPK1/ERK2, MAPK8/JNK1 and MAPK14/p38 and stimulate transcription through the phosphorylation of ELK1 and ATF2. Can also phosphorylate in vitro CREBBP, PRM2, MEF2A and STMN1/OP18. Ref.7 Ref.8 Ref.9 Ref.11 Ref.12 Ref.13 Ref.17 Ref.18 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activated by Ca2+/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows phosphorylation of Thr-200 within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of Thr-200 results in a 10-20-fold increase in total activity to generate Ca2+/calmodulin-independent activity. Autophosphorylation of the N-terminus Ser-12 and Ser-13 is required for full activation. Inactivated by protein phosphatase 2A (PPP2CA/PPP2CB) which dephosphorylates Thr-200, thereby terminating autonomous activity and helping to maintain the enzyme in its autoinhibited state. Ref.10 Ref.15 Ref.16 |
| Subunit structure | Monomer By similarity. Interacts with protein phosphatase 2A (PPP2CA/PPP2CB); the interaction is mutually exclusive with binding to Ca2+/calmodulin. Ref.15 |
| Subcellular location | Cytoplasm. Nucleus. Note: Localized in hippocampal neuron nuclei. In spermatids, associated with chromatin and nuclear matrix By similarity. Ref.8 Ref.9 |
| Tissue specificity | Expressed in brain, thymus, CD4 T-cells, testis and epithelial ovarian cancer tissue. Ref.6 Ref.7 Ref.14 |
| Developmental stage | Expressed during differentiation of monocyte-derived dendritic cells (at protein level). Ref.17 |
| Domain | The autoinhibitory domain overlaps with the calmodulin binding region and interacts in the inactive folded state with the catalytic domain as a pseudosubstrate. Ref.7 Ref.16 |
| Post-translational modification | Phosphorylated by CaMKK1 and CaMKK2 on Thr-200. Dephosphorylated by protein phosphatase 2A. Autophosphorylated on Ser-12 and Ser-13. Ref.10 Ref.15 Ref.19 Glycosylation at Ser-189 modulates the phosphorylation of CaMK4 at Thr-200 and negatively regulates its activity toward CREB1 in basal conditions and during early inomycin stimulation. |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. Contains 1 protein kinase domain. |
| Sequence caution | The sequence AAH16695.2 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 473 | 473 | Calcium/calmodulin-dependent protein kinase type IV | PRO_0000086106 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 46 – 300 | 255 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 52 – 60 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 305 – 321 | 17 | Autoinhibitory domain | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 306 – 323 | 18 | PP2A-binding | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 322 – 341 | 20 | Calmodulin-binding Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 164 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 75 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 12 | 1 | Phosphoserine; by autocatalysis Ref.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 13 | 1 | Phosphoserine; by autocatalysis Ref.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 200 | 1 | Phosphothreonine; by CaMKK1 and CaMKK2 Ref.10 Ref.15 Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 336 | 1 | Phosphoserine; by autocatalysis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 360 | 1 | Phosphoserine Ref.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 57 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 58 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 137 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 189 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 344 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 345 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 356 | 1 | O-linked (GlcNAc) Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 150 | 1 | E → G in a lung adenocarcinoma sample; somatic mutation. Ref.26 | VAR_040604 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | D → N. Ref.26 Corresponds to variant rs35548075 [ dbSNP | Ensembl ]. | VAR_040605 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 465 | 1 | Q → R. Ref.26 Corresponds to variant rs56360861 [ dbSNP | Ensembl ]. | VAR_040606 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 469 | 1 | I → M in a lung large cell carcinoma sample; somatic mutation. Ref.26 | VAR_040607 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 12 | 1 | S → A: Loss of activity. Ref.10 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 13 | 1 | S → A: Loss of activity. Ref.10 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 57 – 58 | 2 | TS → AA: Loss of phosphorylation of CREB1. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 75 | 1 | K → E: Loss of activity; dominant negative form. Ref.13 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 189 | 1 | S → A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity. Ref.15 Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 200 | 1 | T → A: Loss of activation by CaMKK1 or CaMKK2. Ref.11 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 309 – 312 | 4 | HMDT → DEDD: Fully active Ca2+/CaM-independent kinase; when associated with 320-A-A-321. Ref.7 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 320 – 321 | 2 | FN → DD: Fully active Ca2+/CaM-independent kinase; when associated with 309-A--A-312. Loss of interaction with PPP2CA/PPP2CB. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 38 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 42 – 44 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 54 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 65 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 66 – 68 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 71 – 78 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 91 – 95 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 104 – 109 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 111 – 118 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 126 – 130 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 138 – 157 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 167 – 169 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 176 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 181 – 183 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 205 – 207 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 210 – 213 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 221 – 236 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 247 – 255 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 263 – 268 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 271 – 278 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 285 – 287 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 291 – 296 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 298 – 301 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 311 – 335 | 25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "cDNA cloning and expression of human calmodulin-dependent protein kinase IV." Kitani T., Okuno S., Fujisawa H. J. Biochem. 115:637-640(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The cDNA sequence and characterization of the Ca2+/calmodulin-dependent protein kinase-Gr from human brain and thymus." Bland M.M., Monroe R.S., Ohmstede C.A. Gene 142:191-197(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Cerebellum and Thymus. |
| [3] | "A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1." Mosialos G., Hanissian S.H., Jawahar S., Vara L., Kieff E., Chatila T.A. J. Virol. 68:1697-1705(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Blood. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Lung. |
| [6] | "Expression of a Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, in human T lymphocytes. Regulation of kinase activity by T cell receptor signaling." Hanissian S.H., Frangakis M., Bland M.M., Jawahar S., Chatila T.A. J. Biol. Chem. 268:20055-20063(1993) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [7] | "Activation mechanisms for Ca2+/calmodulin-dependent protein kinase IV. Identification of a brain CaM-kinase IV kinase." Tokumitsu H., Brickey D.A., Glod J., Hidaka H., Sikela J., Soderling T.R. J. Biol. Chem. 269:28640-28647(1994) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, DOMAIN AUTOINHIBITORY, MUTAGENESIS OF 309-HIS--THR-312 AND 320-PHE-ASN-321. |
| [8] | "Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression." Matthews R.P., Guthrie C.R., Wailes L.M., Zhao X., Means A.R., McKnight G.S. Mol. Cell. Biol. 14:6107-6116(1994) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF CREB1, SUBCELLULAR LOCATION. |
| [9] | "CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression." Bito H., Deisseroth K., Tsien R.W. Cell 87:1203-1214(1996) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [10] | "A unique phosphorylation-dependent mechanism for the activation of Ca2+/calmodulin-dependent protein kinase type IV/GR." Chatila T., Anderson K.A., Ho N., Means A.R. J. Biol. Chem. 271:21542-21548(1996) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, PHOSPHORYLATION AT SER-12; SER-13 AND THR-200, MUTAGENESIS OF SER-12 AND SER-13. |
| [11] | "Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade." Enslen H., Tokumitsu H., Stork P.J., Davis R.J., Soderling T.R. Proc. Natl. Acad. Sci. U.S.A. 93:10803-10808(1996) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF ELK1; JUN AND ATF2, MUTAGENESIS OF THR-200. |
| [12] | "Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18." Melander Gradin H., Marklund U., Larsson N., Chatila T.A., Gullberg M. Mol. Cell. Biol. 17:3459-3467(1997) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF STMN1. |
| [13] | "Ca(2+)-dependent gene expression mediated by MEF2 transcription factors." Blaeser F., Ho N., Prywes R., Chatila T.A. J. Biol. Chem. 275:197-209(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF MEF2D, MUTAGENESIS OF LYS-75. |
| [14] | "Ca(2+)/calmodulin-dependent protein kinase IV expression in epithelial ovarian cancer." Takai N., Miyazaki T., Nishida M., Nasu K., Miyakawa I. Cancer Lett. 183:185-193(2002) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [15] | "Regulation and function of the calcium/calmodulin-dependent protein kinase IV/protein serine/threonine phosphatase 2A signaling complex." Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R. J. Biol. Chem. 279:31708-31716(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, INTERACTION WITH PROTEIN PHOSPHATASE 2A, PHOSPHORYLATION AT THR-200, MUTAGENESIS OF 320-PHE-ASN-321. |
| [16] | "The autonomous activity of calcium/calmodulin-dependent protein kinase IV is required for its role in transcription." Chow F.A., Anderson K.A., Noeldner P.K., Means A.R. J. Biol. Chem. 280:20530-20538(2005) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, PROTEIN PHOSPHATASE 2A BINDING DOMAIN. |
| [17] | "Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells." Illario M., Giardino-Torchia M.L., Sankar U., Ribar T.J., Galgani M., Vitiello L., Masci A.M., Bertani F.R., Ciaglia E., Astone D., Maulucci G., Cavallo A., Vitale M., Cimini V., Pastore L., Means A.R., Rossi G., Racioppi L. Blood 111:723-731(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN DENDRITIC CELLS LIFESPAN REGULATION, DEVELOPMENTAL STAGE. |
| [18] | "Upregulation of calcium/calmodulin-dependent protein kinase IV improves memory formation and rescues memory loss with aging." Fukushima H., Maeda R., Suzuki R., Suzuki A., Nomoto M., Toyoda H., Wu L.J., Xu H., Zhao M.G., Ueda K., Kitamoto A., Mamiya N., Yoshida T., Homma S., Masushige S., Zhuo M., Kida S. J. Neurosci. 28:9910-9919(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [19] | "Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification." Dias W.B., Cheung W.D., Wang Z., Hart G.W. J. Biol. Chem. 284:21327-21337(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT THR-57 SER-58; SER-137; SER-189; SER-344; SER-345 AND SER-356, PHOSPHORYLATION AT THR-200, IDENTIFICATION BY MASS SPECTROMETRY, MUTAGENESIS OF 57-THR-SER-58 AND SER-189. |
| [20] | "Calmodulin-dependent protein kinase IV: regulation of function and expression." Krebs J. Biochim. Biophys. Acta 1448:183-189(1998) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION, REVIEW ON ENZYME REGULATION. |
| [21] | "Calmodulin-kinases: modulators of neuronal development and plasticity." Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A., Soderling T.R. Neuron 59:914-931(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION IN NEURONAL PLASTICITY. |
| [22] | "Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller." Racioppi L., Means A.R. Trends Immunol. 29:600-607(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON INVOLVEMENT IN IMMUNE AND INFLAMMATORY RESPONSE. |
| [23] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [24] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [25] | "Crystal structure of human CAMK4 in complex with 4-amino(sulfamoyl-phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)." Muniz J.R.C., Rellos P., Gileadi O., Fedorov O., Filippakopoulos P., Salah E., Pike A., Phillips C., Niesen F., Shrestha L., Burgess-Brown N., Bullock A., Berridge G., Vondelft F., Edwards A.M., Bountra C., Arrowsmith C.H., Weigelt J., Knapp S. Submitted (NOV-2008) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.17 ANGSTROMS) OF 15-340 IN COMPLEX WITH INHIBITOR. |
| [26] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLY-150; ASN-178; ARG-465 AND MET-469. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | D30742 mRNA. Translation: BAA06403.1. L17000 mRNA. Translation: AAA35639.1. L24959 mRNA. Translation: AAA18251.1. CH471086 Genomic DNA. Translation: EAW49033.1. CH471086 Genomic DNA. Translation: EAW49034.1. BC016695 mRNA. Translation: AAH16695.2. Different initiation. BC025687 mRNA. Translation: AAH25687.1. | ||||||||||||
| IPI | IPI00430411. | ||||||||||||
| PIR | A53036. | ||||||||||||
| RefSeq | NP_001735.1. NM_001744.4. | ||||||||||||
| UniGene | Hs.591269. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q16566. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-41997N. | ||||||||||||
| IntAct | Q16566. 1 interaction. | ||||||||||||
| STRING | 9606.ENSP00000282356. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q16566. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 2499586. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q16566. | ||||||||||||
| PeptideAtlas | Q16566. | ||||||||||||
| PRIDE | Q16566. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 814. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000282356; ENSP00000282356; ENSG00000152495. ENST00000512453; ENSP00000422634; ENSG00000152495. | ||||||||||||
| GeneID | 814. | ||||||||||||
| KEGG | hsa:814. | ||||||||||||
| UCSC | uc003kpf.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 814. | ||||||||||||
| GeneCards | GC05P110587. | ||||||||||||
| HGNC | HGNC:1464. CAMK4. | ||||||||||||
| HPA | CAB004347. HPA011753. HPA017206. | ||||||||||||
| MIM | 114080. gene. | ||||||||||||
| neXtProt | NX_Q16566. | ||||||||||||
| PharmGKB | PA26050. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOGENOM | HOG000233016. | ||||||||||||
| HOVERGEN | HBG108055. | ||||||||||||
| InParanoid | Q16566. | ||||||||||||
| KO | K05869. | ||||||||||||
| OMA | CEQFGLS. | ||||||||||||
| PhylomeDB | Q16566. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.11.17. 2681. | ||||||||||||
| Pathway_Interaction_DB | nfat_3pathway. Role of Calcineurin-dependent NFAT signaling in lymphocytes. hdac_classii_pathway. Signaling events mediated by HDAC Class II. pi3kplctrkpathway. Trk receptor signaling mediated by PI3K and PLC-gamma. | ||||||||||||
| Reactome | REACT_111102. Signal Transduction. REACT_116125. Disease. REACT_13685. Neuronal System. REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q16566. | ||||||||||||
| Bgee | Q16566. | ||||||||||||
| CleanEx | HS_CAMK4. | ||||||||||||
| Genevestigator | Q16566. | ||||||||||||
| GermOnline | ENSG00000152495. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] | ||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. | ||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q16566. | ||||||||||||
| ChEMBL | CHEMBL2494. | ||||||||||||
| ChiTaRS | CAMK4. human. | ||||||||||||
| EvolutionaryTrace | Q16566. | ||||||||||||
| GenomeRNAi | 814. | ||||||||||||
| NextBio | 3300. | ||||||||||||
| PMAP-CutDB | Q16566. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KCC4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q16566 Secondary accession number(s): D3DSZ7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
